IL85144A - Controlled release oral pharmaceutical compositions containing cyclic carboxylic acid esters or their polymers as carrier or coating material and their preparation - Google Patents

Controlled release oral pharmaceutical compositions containing cyclic carboxylic acid esters or their polymers as carrier or coating material and their preparation

Info

Publication number
IL85144A
IL85144A IL85144A IL8514488A IL85144A IL 85144 A IL85144 A IL 85144A IL 85144 A IL85144 A IL 85144A IL 8514488 A IL8514488 A IL 8514488A IL 85144 A IL85144 A IL 85144A
Authority
IL
Israel
Prior art keywords
polymers
carboxylic acid
acid esters
preparation
carrier
Prior art date
Application number
IL85144A
Other languages
English (en)
Other versions
IL85144A0 (en
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of IL85144A0 publication Critical patent/IL85144A0/xx
Publication of IL85144A publication Critical patent/IL85144A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL85144A 1987-01-21 1988-01-20 Controlled release oral pharmaceutical compositions containing cyclic carboxylic acid esters or their polymers as carrier or coating material and their preparation IL85144A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873701625 DE3701625A1 (de) 1987-01-21 1987-01-21 Perorale arzneimittelzubereitung mit verzoegerter wirkstofffreigabe

Publications (2)

Publication Number Publication Date
IL85144A0 IL85144A0 (en) 1988-06-30
IL85144A true IL85144A (en) 1991-06-30

Family

ID=6319213

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85144A IL85144A (en) 1987-01-21 1988-01-20 Controlled release oral pharmaceutical compositions containing cyclic carboxylic acid esters or their polymers as carrier or coating material and their preparation

Country Status (14)

Country Link
EP (1) EP0275961B1 (da)
JP (1) JP2744240B2 (da)
KR (1) KR970002615B1 (da)
AT (1) ATE106718T1 (da)
AU (1) AU605824B2 (da)
CA (1) CA1329767C (da)
DE (2) DE3701625A1 (da)
DK (1) DK23588A (da)
FI (1) FI93425C (da)
IL (1) IL85144A (da)
MX (1) MX10146A (da)
NO (1) NO175352C (da)
NZ (1) NZ223228A (da)
ZA (1) ZA88358B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981696A (en) * 1986-12-22 1991-01-01 E. I. Du Pont De Nemours And Company Polylactide compositions
US4902515A (en) * 1988-04-28 1990-02-20 E. I. Dupont De Nemours And Company Polylactide compositions
FR2634770B1 (fr) * 1988-07-29 1990-10-05 Rhone Poulenc Chimie Composition polyester erodable contenant de l'iode pour le traitement des eaux
EP0423484B1 (de) * 1989-10-16 1993-11-03 PCD-Polymere Gesellschaft m.b.H. Pressling mit retardierter Wirkstofffreisetzung
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
DE19500977C2 (de) * 1995-01-14 1999-01-07 Lohmann Therapie Syst Lts Feste Arzneimittelform mit in polymerem Material verteiltem Wirkstoff
DE19908753C2 (de) 1999-02-20 2003-10-02 Jenapharm Gmbh Bioabbaubare, injizierbare Oligomer-Polymer-Zusammensetzung
ES2750686T3 (es) 2014-05-30 2020-03-26 Translate Bio Inc Lípidos biodegradables para la administración de ácidos nucleicos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
CA1098443A (en) * 1977-05-20 1981-03-31 Namassivaya Doddi Absorbable p-dioxanone polymer-drug compositions
DE2824112A1 (de) * 1978-06-01 1979-12-06 Garching Instrumente Mikropellets, verfahren zu ihrer herstellung und deren verwendung
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS5966425A (ja) * 1982-10-08 1984-04-14 Mitsui Toatsu Chem Inc 生体分解性重合体を用いた微小粒子の製造方法
FR2557459B1 (fr) * 1984-01-02 1986-05-30 Lhd Lab Hygiene Dietetique Matrice inerte a base de polycaprolactone pour administration orale d'un medicament, et procede de preparation de la forme galenique comprenant cette matrice

Also Published As

Publication number Publication date
NO880230L (no) 1988-07-22
EP0275961B1 (de) 1994-06-08
DK23588D0 (da) 1988-01-20
FI93425C (fi) 1995-04-10
FI93425B (fi) 1994-12-30
AU1065388A (en) 1988-07-28
EP0275961A2 (de) 1988-07-27
MX10146A (es) 1993-09-01
NZ223228A (en) 1990-12-21
DE3889933D1 (de) 1994-07-14
DK23588A (da) 1988-07-22
KR880008806A (ko) 1988-09-13
NO175352C (no) 1994-10-05
ATE106718T1 (de) 1994-06-15
NO880230D0 (no) 1988-01-20
NO175352B (no) 1994-06-27
EP0275961A3 (en) 1990-11-22
CA1329767C (en) 1994-05-24
ZA88358B (en) 1989-09-27
FI880210A0 (fi) 1988-01-19
JPS6419025A (en) 1989-01-23
IL85144A0 (en) 1988-06-30
FI880210A (fi) 1988-07-22
DE3701625A1 (de) 1988-08-04
JP2744240B2 (ja) 1998-04-28
AU605824B2 (en) 1991-01-24
KR970002615B1 (ko) 1997-03-06

Similar Documents

Publication Publication Date Title
NO884474L (no) Implanterbart, biologisk nedbrytbart virkestoff-frigjoeringssystem.
FI885460A (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
AU7452887A (en) Controlled absorption pharmaceutical composition
NO893021D0 (no) Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228.
HUT43843A (en) Process for production of derivatives of benzimidasole and medical compounds containing thereof
IL85144A (en) Controlled release oral pharmaceutical compositions containing cyclic carboxylic acid esters or their polymers as carrier or coating material and their preparation
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
FR2692263B1 (fr) Procédé de préparation d'esters cycliques d'acides-alpha-hydroxycarboxyliques.
CY1814A (en) Oral formulation of buspirone and salts thereof
HU900717D0 (en) Process for preparation of 3-pyroglutamyl-thyazolidine-4-carboxylic acid derivatives and pharmaceutical compositions containing that compounds
EG18643A (en) Pharmaceutical compositions containing trapidil,a process for the preparation thereof and related therapeutic use

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees